Jasper Therapeutics, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.532 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 17.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Details
| Name | Jasper Therapeutics, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 22 |
| Founded | 2018 |
| Ceo | Jeetinder Mahal |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US4718712023 |
| Cusip | 471871202 |
| Cik | 1788028 |
| Sic | 2836 |
Key executives
| Name | Title |
|---|---|
| Jeetinder Singh Mahal M.B.A. | President, Chief Executive Officer and Director |
| Thomas G. Wiggans | Executive Chairman |
| Dr. Judith Anne Shizuru M.D., Ph.D. | Co-Founder, Member of Scientific Advisory Board and Director |
| Herbert C. Cross CPA | Chief Financial Officer and Corporate Secretary |
| Matthew E. Ros | Chief Operating Officer |
| Alex Gray | Head of Investor Relations |
| Matthew Ford | Senior Vice President of Human Resources |
| Dr. Gregory F. Keenan M.D. | Chief Medical Officer |
| Dr. Wenru Song M.D., Ph.D. | Executive Vice President and Head of Research & Development |
Contact
| Address | 2200 Bridge Pkwy, Suite #102, Redwood City, California 94065, United States |
| Phone | 650-549-1400 |
| Website | https://jaspertx.com |